p53 gene product expression in resected non-small cell carcinoma of the lung, with studies of concurrent cytological preparations and microwave antigen retrieval

Journal of Clinical Pathology

Volumn 50, Issue 4, 1997, Pages 320-323

  Binks, S ^a   Clelland, C A ^a   Ronan, J ^a   Bell, J ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Immunocytochemistry; Lung neoplasm; p53

Indexed keywords

PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MICROWAVE RADIATION; PRIORITY JOURNAL;

EID: 0030929130     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.4.320     Document Type: Article

References (22)

1. Iggo R, Gatter K, Bartek J, Lane DP, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990;335:675-9.
2. Chiba I, Takahashi T, Nau MN, D'Amico D, Curiel DT, Mitsudomi T, et al. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 1990;5:1603-10.
3. Caamano J, Rugeri B, Momiki S, Sickler A, Zhang SY, Klien-Szanto AJP. Detection of p53 in primary lung tumours and non-small cell carcinoma cell lines. Am J Pathol 1991;139:839-45.
4. Wynford-Thomas D. p53 in tumour pathology: can we trust immunohistochemistry? J Pathol 1992;166:329-30.
5. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? - revisited! J Pathol 1994;172:1-4.
6. Cattoretti G, Pileri S, Parravicini C, Becker MHG, Poggi S, Bifulco C, et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 1993;171:83-98.
7. Fontanini G, Bignati S, Bigini D, Merlo GR, Ribecchini A, Angeletti CA, et al. Human non-small cell lung cancer. p53 protein accumulation is an early event and persists during metastatic progression. J Pathol 1994;174:23-31.
8. Korkolopoulou P, Oates J, Crocker J, Edwards C. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferative cell nuclear antigen. J Clin Pathol 1993;46:1093-6.
9. McLaren R, Kuzu I, Dunnill M, Harris A, Lane DP, Gatter KC. The relationship of p53 immunostaining to survival in carcinoma of the lung. Br J Cancer 1992;66:735-8.
10. Westra WH, Offerhaus, J Goodman S, Slebos RJC, Polak M, Baas IO, et al. Overexpression of p53 tumour suppressor gene product in primary lung adenocarcinoma is associated with cigarette smoking. Am J Surg Pathol 1993;17:213-20.
11. Dowell SP, Lane DP, Hall PA. The immunocytochemical detection of p53 protein in cytological preparations: technical considerations. Cytopathologv 1994;5:76-81.
12. McCarty KS, Miller LS, Cox EB, Konrath J, McCarty KS. Oestrogen receptor analysis. Arch Path Lab Med 1985;109: 716-21.
13. Walker C, Robertson LJ, Myskow MW, Pendleton N, Dixon GR. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer 1994;70: 297-303.
14. Porter PL, Gown AM, Kramp SG, Coltera MD. Widespread p53 overexpression in human malignant tumours. Am J Pathol 1992;140:145-53.
15. Vahakangas KH, Samet JM, Metcalf RA, Welsh JA, Bennett WP, Lane DP, et al. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 1992;339:576-80.
16. Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM. Accumulation of p53 protein correlates with a poorer prognosis in human lung cancer. Cancer Res 1992;52:4828-31.
17. Soini Y, Kamel D, Nuorva K, Lane DP, Dahakangas K, Paako P. Low p53 protein expression in salivary gland tumours compared with lung carcinomas. Virchows Arch 1992;421:415-20.
18. Ebina M, Steinberg SM, Mulshine JL, Linnoila RI. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res 1994;54:2496-503.
19. Dalquen P, Sauter G, Torhorst J, Schultheiss E, Jordan P, Lechmann S, et al. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma. J Pathol 1996;178:53-8.
20. Dowell SP, Wilson POG, Derias NW, Lane DP, Hall PA. Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens. Cancer Res 1994;54: 2914-18.
21. Clelland CA, Coates M, King-Wai Low D, Ronan J. p53 gene product detection in mesothelioma. Cytopathology [in press].
22. Murakami I, Fujiwara Y, Yamaoka K, Hiyama K, Ishioka S, Yamakido M. Detection of p53 gene mutation in cytopathology and biopsy specimens from patients with lung cancer. Am J Respir Crit Care Med 1996;154:1117-23.